Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Share, Trends, Analysis And Forecasts Up To 2018

Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, immature blood cells are present in the bone marrow. Symptoms found in patients due to the disease are flu, loss of weight, body ache and pain and spots on skin.

The Acute Myeloid Leukemia (AML) therapeutics market was USD 239.3 million in 2011 and this market is forecasted to reach USD 731.1 million in 2018. Future AML therapeutics market shows unprecedented growth at a CAGR of 17.3 % from 2011 to 2018 while in the past, growth rate was only 2.9% from 2005 – 2010. The reasons behind the huge growth rate are increase in ageing population, strong products pipeline, high unmet medical needs and entry of quality products.

For Any Queries Get Solutions With A PDF Sample : http://bit.ly/2fQ4GGf

North America accounted for 62% sales of leukemia drugs in the therapeutics market during 2010 followed by Europe and Asia Pacific. AML therapeutics market will grow and the total growth will depend on pipeline products and metabolic inhibitors, a tyrosine kinase receptor FLT -3 of Novartis and some other capable molecules, improving the therapeutics market.

Globally the numbers of elderly people, 60 years and above are growing and it is expected that this age group will cross the 1.3 billion mark in 2017. Hence the acute myeloid leukemia therapeutics market will also grow. Many AML products are in the pipeline or in different clinical phases that will bring the change in disease treatment.

Leading market players in the acute myeloid leukemia therapeutics market accounted for almost 70-80% market share. Some big companies in the therapeutics market are Bristol-Myers Squibb, Novartis International AG, Roche, Genmab A/S, GlaxoSmithKline Pharmaceuticals Limited; in the future, manufacturing companies such as Pfizer are expected to enter this market and will hold major share.

This market research report analyzes important market segments, and major geographies. This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.